Cargando…

Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires

BACKGROUND: The distribution of Pooideae species varies across Europe. Especially, Timothy is less represented in Southern than in Northern Europe. Since allergenic cross-reactivity between pollens from different grasses is only partial, grass pollen-allergic patients are expected to display differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batard, Thierry, Sanjuan, Amparo, Denis, Laure, Nguyen, Hélène, Montagut, Armelle, Sastre, Joaquín, Rak, Sabina, Cuiné, Jean F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391756/ https://www.ncbi.nlm.nih.gov/pubmed/30858968 http://dx.doi.org/10.1186/s13601-019-0253-z

Ejemplares similares

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis
por: Didier, Alain, et al.
Publicado: (2012)

Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study
por: Shah-Hosseini, Kija, et al.
Publicado: (2017)

Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis
por: Wu, Yu-Chang B., et al.
Publicado: (2014)

Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5
por: Levin, M, et al.
Publicado: (2014)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

Allergy-associated T cell epitope repertoires are surprisingly diverse and include non-IgE reactive antigens
por: Frazier, April, et al.
Publicado: (2014)

Short-Term Exposure of Dactylis glomerata Pollen to Atmospheric Gaseous Pollutants Is Related to an Increase in IgE Binding in Patients with Grass Pollen Allergies
por: Fernández-González, María, et al.
Publicado: (2022)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
por: Hebert, Jacques, et al.
Publicado: (2011)

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
por: Zieglmayer, Petra, et al.
Publicado: (2016)

Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy
por: Thörnqvist, Linnea, et al.
Publicado: (2022)

A survey on the perception of allergy specialists about the reimbursed grass pollen tablets for seasonal allergic rhinitis in Italy
por: Massaro, Ilaria, et al.
Publicado: (2017)

Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy
por: Savi, Eleonora, et al.
Publicado: (2013)

Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax(®)
por: Calderón, Moisés, et al.
Publicado: (2008)

A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
por: Alesina, Roberta, et al.
Publicado: (2012)

Serum IgE profiles in Chinese pollinosis patients with grass pollen sensitisation
por: Li, Jun-Da, et al.
Publicado: (2022)

The IgE repertoire in patients with food allergy resolved at component level
por: Belohlavkova, S, et al.
Publicado: (2013)

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
por: Murphy, Kevin, et al.
Publicado: (2013)

Random mutagenesis and phage display technology as a tool for identifying ige epitopes of the birch pollen allergen Bet v 1
por: Guhsl, Elisabeth Eva, et al.
Publicado: (2014)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis
por: Kiotseridis, Hampus, et al.
Publicado: (2013)

Assessment of Google Trends terms reporting allergies and the grass pollen season in Ukraine
por: Kaidashev, Igor, et al.
Publicado: (2020)

Are Markers of Allergic Inflammation in Grass Pollen Allergy Influenced by H1 Antihistamines?
por: Bocsan, Ioana Corina, et al.
Publicado: (2021)

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children
por: Ronaldson, Sarah, et al.
Publicado: (2014)

Involvement of cross-reactive carbohydrate determinants-specific IgE in pollen allergy testing
por: Yokoi, Hidenori, et al.
Publicado: (2017)

Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
por: Marcucci, Francesco, et al.
Publicado: (2012)

Back to basics: likelihood ratios for olive and grass pollen specific IgE in seasonal allergic rhinitis
por: Manzanares, Bárbara, et al.
Publicado: (2023)

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure
por: Durham, S R, et al.
Publicado: (2014)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017)

Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults
por: Ruggeri, Matteo, et al.
Publicado: (2013)

Ash pollen allergy: reliable detection of sensitization on the basis of IgE to Ole e 1
por: Imhof, Konrad, et al.
Publicado: (2014)

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

Intradermal grass pollen immunotherapy increases T(H)2 and IgE responses and worsens respiratory allergic symptoms
por: Slovick, Anna, et al.
Publicado: (2017)

Biogeographical variation in specific IgE recognition of temperate and subtropical grass pollen allergens in allergic rhinitis patients
por: Kailaivasan, Thina H, et al.
Publicado: (2020)

Sequential IgE-epitopes of ovomucoid exposed by glutathione are relevant in persistent egg allergy
por: Kinaciyan, T, et al.
Publicado: (2013)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
por: Bryson, Rebecca
Publicado: (2012)

Plant Food Allergy Improvement after Grass Pollen Sublingual Immunotherapy: A Case Series
por: Furci, Fabiana, et al.
Publicado: (2021)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Soybean allergy: IgE epitopes of glycinin (Gly m 6), an important soybean allergen
por: Schiller, Dirk, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e1bpol0bf8iq29o23ci6gejt5h